Insider Transactions in Q2 2023 at Viracta Therapeutics, Inc. (VIRX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2023
|
Roger Pomerantz |
BUY
Exercise of conversion of derivative security
|
Direct |
9,035
+11.11%
|
-
|
|
May 25
2023
|
Ivor Royston |
BUY
Exercise of conversion of derivative security
|
Direct |
25,219
+3.53%
|
-
|
|
May 25
2023
|
Daniel R. Chevallard CFO and COO |
SELL
Open market or private sale
|
Direct |
3,635
-3.79%
|
$3,635
$1.42 P/Share
|
|
May 25
2023
|
Daniel R. Chevallard CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,889
+6.7%
|
-
|